“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

28 June 2019
Pharma

Visiongain has launched a new pharma report Top 30 Pharmaceutical Wholesale & Distribution Organizations 2019: Branded Drugs, Generic Drugs, Leading Companies.

The pharmaceutical wholesale and distribution market is vital, providing access to life saving drugs to vast number of people in a timely manner. The market is large, with many opportunities for growth and development during the forecast period.

The establishment of the pharmaceutical wholesale market was driven by manufacturers wanting to outsource distribution to wholesalers to focus on core competencies of R&D and marketing. At the same time, hospitals outsourced inventory management in an effort to reduce investment in this area. These factors created a high demand for a comprehensive wholesale and distribution service.

The lead analyst of the report commented "Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals. Distributing increased volumes of drugs will benefit wholesalers through increased revenues. The increased sales volume will be particularly noticeable in emerging markets, such as China, India and Brazil."

Leading companies featured in the report include Alfresa Holdings, AmerisourceBergen, Anda Inc., Auburn Pharmaceutical Company, Capital Wholesale Drug Company, Cardinal Health, CR Pharmaceutical, CuraScript Special, Dakota Drug, Inc., Fff Enterprises Inc., and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes European Antibiotics Market Report 2021-2031

Penicillin segment holds majority of the market share owing to maximum prescription as well as the most generic manufacturers throughout the industry.

22 June 2021

Read

Visiongain Publishes Companion Diagnostics (CDx) Market Report 2021-2031

Over the last few years, companion diagnostics has gained widespread attention due to the technological advancements, growing demand for precision medicine, and accelerating demand for targeted therapy.

17 June 2021

Read

Visiongain Publishes Cellular Immunotherapy Market Report 2021-2031

Increasing prevalence of cancers and rising demand for advanced therapies for cancer treatment are the major factors driving the demand for cellular immunotherapies.

15 June 2021

Read

Visiongain Publishes Gene Therapy R&D Market Report 2021-2031

Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions.

14 June 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever